Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. MARC ROSEN
Trametinib With and Without Pazopanib Has Potent Preclinical Activity in Thyroid Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models
International Journal of Cancer
Cancer Research
Oncology
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination With Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer
Cancer Research
Cancer Research
Oncology
GC1118, a Novel Anti-Egfr Antibody, Has Potent KRAS Mutation-Independent Antitumor Activity Compared With Cetuximab in Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
LY3009120, a panRAF Inhibitor, Has Significant Anti-Tumor Activity in BRAF and KRAS Mutant Preclinical Models of Colorectal Cancer
Oncotarget
Oncology
Thailandepsins Are New Small Molecule Class I HDAC Inhibitors With Potent Cytotoxic Activity in Ovarian Cancer Cells: A Preclinical Study of Epigenetic Ovarian Cancer Therapy
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Thyroid Cancer Has Increased 12-Fold in Women Since Chernobyl
BMJ
Characterization of Human Follicular Thyroid Cancer Cell Lines in Preclinical Mouse Models
Endocrine Connections
Internal Medicine
Endocrinology
Metabolism
Diabetes
TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Novel PI3K Inhibitor PIK-C98 Displays Potent Preclinical Activity Against Multiple Myeloma
Oncotarget
Oncology
